Siemens Healthineers


Rocking Diagnostics

03/05/21 -"Based on the strong demand for its COVID-19 antigen test as well as for Imaging’s consumables and the closing of the Varian acquisition, management lifted its organic sales growth assumptions as well ..."

Pages
56
Language
English
Published on
03/05/21
You may also be interested by these reports :
07/05/21
Coloplast (Reduce, Denmark) is, fundamentally, an attractive business (AV fundamental strength score of 9/10 vs 7.7 for AV MedTech and 5.4 for AV ...

07/05/21
Coloplast reported mixed Q2/H1 2021 numbers. Sales were up 2% on an organic basis, driven by ostomy (+4%) and urology (+3%). Adjusted EBIT was up 2% ...

07/05/21
Group’s sales momentum accelerated in Q1 driven by a strong show in Audio – both enterprise and consumers divisions reported double-digit growth. ...

07/05/21
We see a certain decoupling, of which the one related to the COVID-19 cases of FMC patients to the global trend is very positive in our view. The ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO